Pre-operative immunotherapy with tumor cryoablation (cryo) plus ipilimumab (ipi) induces potentially favorable systemic and intratumoral immune effects in early stage breast cancer (ESBC) patients

Detalles Bibliográficos
Autores principales: Page, David B, Diab, Adi, Yuan, Jianda, Dong, Zhiwan, Soloman, Stephen B, Patil, Sujata, Hudis, Clifford A, Wolchok, Jedd D, Norton, Larry, McArthur, Heather L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547170/
http://dx.doi.org/10.1186/2051-1426-3-S1-O6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547170/
http://dx.doi.org/10.1186/2051-1426-3-S1-O6

Ejemplares similares